Vaccines Europe - 29 Jan 2021
Although details of the Commission’s proposal for an export visibility mechanism for EU manufactured COVID-19 vaccines remain unclear, if any mechanism does not allow for complete automaticity in clearance of exports, or otherwise goes beyond transmission of factual information meeting transparency expectations, this would risk being a restriction of exports, and would undermine the supply of vaccines in Europe and around the world.
Global supply chains are key to delivering vaccines to protect citizens against COVID-19. It is vital that any measures proposed by the Commission and the Member States do not restrict, hold back, or have other negative impacts on exports of vaccines or the import of key vaccine manufacturing supplies. Risking retaliatory measures from other regions at this crucial moment in the fight against COVID-19 is not in anyone’s best interest.